Literature DB >> 15193922

Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides.

V G Chinchar1, L Bryan, U Silphadaung, E Noga, D Wade, L Rollins-Smith.   

Abstract

The ability of five purified amphibian antimicrobial peptides (dermaseptin-1, temporin A, magainin I, and II, PGLa), crude peptide fractions isolated from the skin of Rana pipiens and R. catesbeiana, and four antimicrobial peptides (AMPs) from hybrid striped bass (piscidin-1N, -1H, -2, and -3) were examined for their ability to reduce the infectivity of channel catfish virus (CCV) and frog virus 3 (FV3). All compounds, with the exception of magainin I, markedly reduced the infectivity of CCV. In contrast to CCV, FV3 was 2- to 4-fold less sensitive to these agents. Similar to an earlier study employing two other amphibian peptides, the agents used here acted rapidly and over a wide, physiologically relevant, temperature range to reduce virus infectivity. These results extend our previous findings and strongly suggest that various amphibian and piscine AMPs may play important roles in protecting fish and amphibians from pathogenic viruses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193922     DOI: 10.1016/j.virol.2004.02.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

1.  Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy.

Authors:  Mareike Hartmann; Marina Berditsch; Jacques Hawecker; Mohammad Fotouhi Ardakani; Dagmar Gerthsen; Anne S Ulrich
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

2.  Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.

Authors:  Jacob A Tennessen; Michael S Blouin
Journal:  J Mol Evol       Date:  2007-10-16       Impact factor: 2.395

3.  Solution and solid-state NMR structural studies of antimicrobial peptides LPcin-I and LPcin-II.

Authors:  Tae-Joon Park; Ji-Sun Kim; Hee-Chul Ahn; Yongae Kim
Journal:  Biophys J       Date:  2011-09-07       Impact factor: 4.033

4.  Amphipathic antimicrobial piscidin in magnetically aligned lipid bilayers.

Authors:  Anna A De Angelis; Christopher V Grant; Matthew K Baxter; Jason A McGavin; Stanley J Opella; Myriam L Cotten
Journal:  Biophys J       Date:  2011-09-07       Impact factor: 4.033

Review 5.  Structural diversity and species distribution of host-defense peptides in frog skin secretions.

Authors:  J Michael Conlon
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

6.  Charged Antimicrobial Peptides Can Translocate across Membranes without Forming Channel-like Pores.

Authors:  Jakob P Ulmschneider
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

7.  Antibacterial, antifungal, anticancer activities and structural bioinformatics analysis of six naturally occurring temporins.

Authors:  Biswajit Mishra; Xiuqing Wang; Tamara Lushnikova; Yingxia Zhang; Radha M Golla; Jayaram Lakshmaiah Narayana; Chunfeng Wang; Timothy R McGuire; Guangshun Wang
Journal:  Peptides       Date:  2018-05-26       Impact factor: 3.750

8.  Diffusion NMR study of complex formation in membrane-associated peptides.

Authors:  Suliman Barhoum; Valerie Booth; Anand Yethiraj
Journal:  Eur Biophys J       Date:  2013-02-07       Impact factor: 1.733

9.  A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.

Authors:  Guofeng Cheng; Ana Montero; Pablo Gastaminza; Christina Whitten-Bauer; Stefan F Wieland; Masanori Isogawa; Brenda Fredericksen; Suganya Selvarajah; Philippe A Gallay; M Reza Ghadiri; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

10.  Atlantic cod piscidin and its diversification through positive selection.

Authors:  Jorge M O Fernandes; Jareeporn Ruangsri; Viswanath Kiron
Journal:  PLoS One       Date:  2010-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.